Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

Philogen S.p.A. nomina Mediobanca – Banca di Credito Finanziario S.p.A., quale intermediario incaricato dell’esecuzione del programma di acquisto di azioni proprie

More details

L’Assemblea degli Azionisti autorizza l’acquisto e la disposizione di azioni proprie ed il Consiglio di Amministrazione approva l’avvio del programma (Price sensitive)

More details

Philogen announces new collaboration with Janssen to discover small molecule therapeutics

More datails

Comunicazione ex art. 85 bis (comma 4-bis) Regolamento Emittenti

Comunicazione ex art. 85 bis (comma 4-bis) Regolamento Emittenti

Philogen provides Corporate Update

Philogen to hold a Webinar at 11 am EST / 4 pm GMT / 5 pm CET on Friday 12th November 2021, Click here to view Press Release 12-11-2021

Il Consiglio Di Amministrazione approva la Posizione Finanziaria Netta relativa al Terzo Trimestre 2021 (Price Sensitive)

Comunicato Stampa 11-11-2021

The Board Of Directors approves the Net Financial Position as 30 September 2021 (Price Sensitive) – Courtesy English Translation

Press Release 11-11-2021

Philogen to attend the Cytokine-Based Cancer Immunotherapies Summit on November 30-December 2 , 2021

Dario Neri, co-founder, CEO and CSO, is giving a presentation to address the question on how to achieve the therapeutic dose at the tumor site with cytokine-based...

Philogen to attend the Antibody Engineering & Therapeutics on December 12-16 , 2021

Dario Neri, co-founder, CEO and CSO, is giving a presentation focused on Tripokin, a novel fusion protein capable of an exceptionally selective uptake at the tumor...

Philogen S.p.A. announces its Q3 2021 Results on Thursday 11th November 2021 and holds a Webinar on Friday 12th November 2021

Philogen to hold a Webinar at 11 am EST / 4 pm GMT / 5 pm CEST on Friday 12th November 2021.   Register in advance for this webinar:...

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions